Konakion Mm Ampoules (Phytomenadione)

Phytomenadione serves as a cofactor for the gamma‑carboxylation of specific clotting factors, enabling them to bind calcium and phospholipid surfaces. This biochemical step restores the functional activity of factors II, VII, IX, X and proteins C and S, facilitating normal blood clot formation.

The dose of Konakion Mm Ampoules is determined by the prescribing healthcare professional based on the patient’s clinical condition, age, weight, and laboratory values. Dosage regimens are individualized and should follow local clinical guidelines.

Safety data for phytomenadione in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother or infant outweighs any possible risk, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Konakion Mm provides phytomenadione in a sterile ampoule suitable for intravenous administration, offering rapid correction of deficiency. Compared with oral vitamin K tablets, the injectable form achieves faster plasma levels, which is advantageous in emergency reversal of anticoagulation or in neonates unable to take oral medication.

Konakion Mm Ampoules should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use to maintain stability.

The ampoule is intended for intravenous injection by a qualified healthcare professional. It may be diluted in compatible IV fluids according to the prescribing information and administered slowly to reduce the risk of adverse reactions.

Serious adverse events include anaphylactic reactions, which can present with urticaria, respiratory distress, or hypotension, and rare thrombotic complications. Immediate medical attention is required if any signs of severe allergy or unexpected clot formation occur.

Patients with a known hypersensitivity to phytomenadione or any component of the formulation should avoid using Konakion Mm. Caution is also advised in individuals with severe liver disease, uncontrolled bleeding disorders, or those receiving multiple anticoagulant agents without appropriate monitoring.